MedTrace Logo

The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions

NCT04813770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1113

Last updated 2021-05-10

No results posted yet for this study

Summary

Uptake of vaccination against COVID-19 is key to controlling the pandemic. However, a significant proportion of people report that they do not intend to have a vaccine, often because of concerns they have about its side effects or safety. It is important to identify ways to communicate information about the vaccines that facilitate informed decisions rather than promoting uptake through coercion. This study will assess whether theory-based messages can change beliefs and increase intentions to receive a COVID-19 vaccine in Scotland. The messages will be based on publicly available information about the need for COVID-19 vaccination and the safety of the vaccines, and structured to address specific types of treatment beliefs. Participants will be randomised to either a group shown the messages or a control group shown general information messages about the COVID-19 virus and vaccination programme. By comparing the two groups we aim to test what impact the theory-based messages have on intentions and beliefs about COVID-19 vaccination.

Conditions

  • Vaccination
  • Covid19

Interventions

BEHAVIORAL

Theory-based messages

COVID-19 vaccination information structured to address vaccination necessity and concerns.

BEHAVIORAL

General messages

General messages about the COVID-19 virus and the vaccination programme.

Sponsors & Collaborators

  • University of Glasgow

    lead OTHER

Principal Investigators

  • Katie Robb · University of Glasgow

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-06
Primary Completion
2021-04-26
Completion
2021-04-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04813770 on ClinicalTrials.gov